AI-Powered Multi-Omic Integration Reveals Genetic Architecture Of COVID-19 Severity

Abstract

This leverages artificial intelligence and multi-omic integration to systematically characterize the genetic determinants of COVID-19 severity across diverse populations. The article employs advanced machine learning approaches, including deep neural networks, ensemble methods, and feature selection algorithms, to analyze whole-genome sequencing data integrated with transcriptomic, proteomic, and metabolomic datasets from participants stratified by clinical severity, ranging from asymptomatic carriers to patients requiring mechanical ventilation. The article identifies critical genetic variants affecting interferon signaling pathways, human leukocyte antigen-mediated antigen presentation, complement activation cascades, and inflammatory response regulation that govern differential disease susceptibility and outcomes. These articles reveal that individual responses to SARS-CoV-2 infection reflect complex polygenic architectures, epistatic interactions, and gene-environment dependencies rather than simplistic single-gene models. The AI-driven discoveries illuminate molecular mechanisms underlying clinically observed heterogeneity, including asymptomatic infection, rapid progression to severe disease, and differential treatment responses, while highlighting population-specific genetic architectures that underscore the importance of inclusive genomic research. Beyond immediate clinical implications for risk stratification, therapeutic selection, and vaccine development, this article establishes a robust methodological framework demonstrating the transformative potential of integrating computational genomics with multi-omic sciences to address complex biomedical challenges, providing a proof-of-concept for future pandemic preparedness initiatives where rapid genetic characterization could inform public health interventions and precision medicine strategies globally.